Dermatology · Wauwatosa, WI
NPI
1790865806
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
10000 W Bluemound Rd
Wauwatosa, WI, 53226
Phone (414) 454-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
1,204 services
Medicare patients, 2024
371
Average age 73
Drug cost, 2024
$2.4M
1,072 prescriptions
Company payments, 2025
$84K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth B Gordon was code 96900 (skin), 301 times for 11 patients. In total Kenneth B Gordon billed 1,204 services in 24 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96900 Skin | Office | 301 | 11 | $17.84 | $5,371 |
| 99213 Office E&M - Established | Facility | 224 | 185 | $42.12 | $9,435 |
| 17003 Destruction Skin Lesion | Facility | 206 | 53 | $1.36 | $280 |
| 99214 Office E&M - Established | Facility | 121 | 94 | $66.88 | $8,092 |
| 17000 Destruction Skin Lesion | Facility | 96 | 88 | $28.90 | $2,774 |
| 99203 Office E&M - New | Facility | 54 | 54 | $46.40 | $2,506 |
| 17110 Destruction Skin Lesion | Facility | 48 | 46 | $48.11 | $2,309 |
| 11102 Skin Biopsy | Facility | 44 | 42 | $18.82 | $828 |
By year: 2022 $38K for 1,214 services; 2023 $36K for 992 services; 2024 $35K for 1,204 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth B Gordon prescribed most often to Medicare patients was Ketoconazole, with 121 prescriptions and refills. In total Kenneth B Gordon wrote 1,072 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 121 | 143 | 54 | $1,814 |
| Clobetasol Propionate Generic | 112 | 127 | 40 | $7,578 |
| Triamcinolone Acetonide Generic | 96 | 117 | 49 | $1,344 |
| Fluocinonide Generic | 75 | 76 | 29 | $3,650 |
| Methotrexate Methotrexate Sodium | 37 | 80 | 11 | $597 |
| Skyrizi Risankizumab-Rzaa | 36 | 96 | Under 11 | $737K |
| Tacrolimus Generic | 34 | 36 | 16 | $5,382 |
| Taltz Autoinjector Ixekizumab | 33 | 37 | Under 11 | $258K |
| Valacyclovir Valacyclovir Hcl | 23 | 41 | 11 | $1,064 |
| Clindamycin Phosphate Generic | 21 | 27 | Under 11 | $835 |
| Doxycycline Monohydrate Generic | 20 | 30 | Under 11 | $704 |
| Skyrizi Pen Risankizumab-Rzaa | 19 | 51 | Under 11 | $380K |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 19 | 19 | Under 11 | $1,346 |
| Dupixent Pen Dupilumab | 19 | 19 | Under 11 | $73K |
| Metronidazole Generic | 19 | 21 | Under 11 | $785 |
Brand drugs: 239 claims; generic drugs: 833 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth B Gordon $84K ($84K in general payments such as food, travel and fees) from 13 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $27K |
| Janssen Biotech, Inc. JNJ | 18 | $15K |
| Amgen Inc. AMGN | 27 | $9,364 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $7,178 |
| Eli Lilly and Company LLY | 4 | $5,633 |
| UCB, Inc. UCB.BR | 1 | $5,400 |
| Boehringer Ingelheim International GmbH | 10 | $4,858 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $2,500 |
| Incyte Corporation INCY | 3 | $2,433 |
| Pfizer Inc. PFE | 2 | $2,389 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.